Stockholders' Equity - Schedule of Nonvested Share Activity (Details) - 2021 Equity Incentive Plan and the Inducement Awards shares in Thousands, $ in Thousands |
6 Months Ended |
|---|---|
|
Aug. 03, 2024
USD ($)
shares
| |
| RSUs and RSAs | |
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |
| Nonvested/outstanding, February 3, 2024 | 9,618 |
| Granted | 14,736 |
| Vested and delivered/exercised | (3,471) |
| Forfeited/expired | (4,034) |
| Nonvested/outstanding, August 3, 2024 | 16,849 |
| Unrecognized compensation expense as of August 3, 2024 | $ | $ 56,796 |
| Weighted average remaining expense period as of August 3, 2024 | 2 years 1 month 6 days |
| Options | |
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |
| Options outstanding, February 3, 2024 | 6,310 |
| Granted | 15,213 |
| Forfeited/expired | (8,812) |
| Options outstanding, August 3, 2024 | 12,711 |
| Unrecognized compensation expense as of August 3, 2024 | $ | $ 14,266 |
| Weighted average remaining expense period as of August 3, 2024 | 2 years 6 months |
| X | ||||||||||
- Definition Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of cost to be recognized for option under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|